Status: Not yet recruiting
Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines
Clinical trial to assess the real-world effectiveness of Obagi® Saypha® MagIQ™ Injectable Hyaluronic Acid (HA) gel for the treatment of mild-to-moderate facial aging, including volume loss, fine lines, and skin laxity, following treatment administered using routine clinical injection techniques over the course of 60 days.
Participants needed: 100
Trial details
Phase: Phase 4Age: 30-75Biological sex: AllType: InterventionalSponsor: Goldman, Butterwick, Fitzpatrick and GroffUpdated: Feb 19, 2026Locations: 1
Eligibility criteria
Adult subjects aged 30 to 75 years at the time of screening/baseline. [+7]
Prior use of injectable treatments to the face within the past 12 months, includ... [+17]